MEGAN SCHRINER: Open Payments
NPI 1770888117 · GRAND ISLAND, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$990 in 9 payments from 7 companies in 2025. Trend: 2023 $1,688 · 2024 $3,423 · 2025 $990
Honoraria: $700Food & beverage: $255Education: $35
| Company | Payments | Amount |
|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | 2 | $777 |
| Geron Corporation | 1 | $67 |
| ABBVIE INC. | 2 | $55 |
| AstraZeneca Pharmaceuticals LP | 1 | $35 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Octapharma USA, Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $16 |
Products named: FIRDAPSE, RYTELO, EPKINLY, IMFINZI, OCTAGAM IMMUNE GLOBULIN (HUMAN), Vyloy.
Industry payments across NE — which companies pay providers there.
